Adaptive Biotechnologies is trading at $25.41, up 4.05%, apparently supported by a biotech sector rally.
- XBI rose 2.10% during the regular session; no stronger company-specific catalyst surfaced.
- The latest company release found was dated October 14 and announced third-quarter results for November 4; it was not a new October 21 catalyst.
- Volume information is unavailable in the supplied price context.